Journal article icon

Journal article

NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study

Abstract:
BACKGROUND: Blood neurofilament light chain (NfL) is increasingly considered as a key trial biomarker in genetic frontotemporal dementia (gFTD). We aimed to facilitate the use of NfL in gFTD multicentre trials by testing its (1) reliability across labs; (2) reliability to stratify gFTD disease stages; (3) comparability between blood matrices and (4) stability across recruiting sites. METHODS: Comparative analysis of blood NfL levels in a large gFTD cohort (GENFI) for (1)-(4), with n=344 samples (n=148 presymptomatic, n=11 converter, n=46 symptomatic subjects, with mutations in C9orf72, GRN or MAPT; and n=139 within-family controls), each measured in three different international labs by Simoa HD-1 analyzer. RESULTS: NfL revealed an excellent consistency (intraclass correlation coefficient (ICC) 0.964) and high reliability across the three labs (maximal bias (pg/mL) in Bland-Altman analysis: 1.12±1.20). High concordance of NfL across laboratories was moreover reflected by high areas under the curve for discriminating conversion stage against the (non-converting) presymptomatic stage across all three labs. Serum and plasma NfL were largely comparable (ICC 0.967). The robustness of NfL across 13 recruiting sites was demonstrated by a linear mixed effect model. CONCLUSIONS: Our results underline the suitability of blood NfL in gFTD multicentre trials, including cross-lab reliable stratification of the highly trial-relevant conversion stage, matrix comparability and cross-site robustness
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/jnnp-2023-332464
Publication website:
https://discovery.ucl.ac.uk/10186136/1/jnnp-2023-332464.full.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0001-5901-2629
More by this author
Role:
Author
ORCID:
0000-0002-7250-8597
More by this author
Role:
Author
ORCID:
0000-0002-4133-7182
More by this author
Role:
Author
ORCID:
0000-0003-3930-4354
More by this author
Role:
Author
ORCID:
0000-0002-1934-6162


More from this funder
Funder identifier:
10.13039/501100010969
Grant:
N/A
More from this funder
Funder identifier:
10.13039/100000957
Grant:
ADSF-21-831376-C
ADSF-21-831377-C
ADSF-21-831381-C
More from this funder
Funder identifier:
10.13039/100016948
Grant:
N/A
More from this funder
Funder identifier:
10.13039/100007436
Grant:
N/A


Publisher:
BMJ Publishing Group
Journal:
Journal of Neurology, Neurosurgery and Psychiatry More from this journal
Volume:
95
Issue:
9
Pages:
822-828
Publication date:
2024-01-19
Acceptance date:
2023-12-31
DOI:
EISSN:
1468-330X
ISSN:
0022-3050


Language:
English
Keywords:
Pubs id:
1700353
Local pid:
pubs:1700353
Source identifiers:
W4391109464
Deposit date:
2026-06-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP